Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 10/21: (KLAC) (ISRG) (SNDK) Higher; (SNTA) (VMW) (TWTR) Lower (more...)

October 21, 2015 9:27 AM
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) 66.7% LOWER; announced that the Company has decided to terminate the Phase 3 GALAXY-2 trial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles